Periungual and subungual pyogenic granuloma following anti-TNF-α therapy: is it the first case?

Dermatol Ther. 2013 Nov-Dec;26(6):493-5. doi: 10.1111/dth.12022. Epub 2013 Apr 1.

Abstract

Tumor necrosis factor-alpha (TNF-α) antagonists have advanced treatment of psoriasis and other chronic inflammatory diseases but are not free of adverse effects. Pyogenic granuloma is yet described in literature as a dermatological side effect of multiple drugs such as retinoids, antiretroviral, and antineoplastic drugs but, to the best of our knowledge, it has never been reported among the adverse skin reactions following anti-TNF-α therapy. We report on a 20-year-old Caucasian man with psoriatic arthritis who developed multiple eruptive periungual and subungual pyogenic granulomas following treatment with TNF-α antagonist etanercept.

Keywords: etanercept; psoriasis; pyogenic granuloma.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antirheumatic Agents / administration & dosage
  • Antirheumatic Agents / adverse effects*
  • Arthritis, Psoriatic / drug therapy*
  • Etanercept
  • Granuloma, Pyogenic / chemically induced*
  • Granuloma, Pyogenic / diagnosis
  • Humans
  • Immunoglobulin G / administration & dosage
  • Immunoglobulin G / adverse effects*
  • Injections, Subcutaneous
  • Male
  • Nail Diseases / chemically induced*
  • Nail Diseases / diagnosis
  • Psoriasis / drug therapy*
  • Receptors, Tumor Necrosis Factor / administration & dosage
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*
  • Young Adult

Substances

  • Antirheumatic Agents
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Etanercept